Trial intelligence / Profile preview

Quality of Life Study in Adults With Facial Eczema

NCT00120302Phase 4Completed

Sponsor
Novartis
Start
Mar 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Novartis. Started Mar 2005; status: completed.

02

Drugs

Pimecrolimus vehicle + topical corticosteroid
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00120302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00120302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call